跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ninlaro - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Ninlaro
Approved
STANDARD
Ninlaro
Haupt Pharma Amareg GmbH
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
2523a71a496105f6
Company
Haupt Pharma Amareg GmbH
Type
Standard
Approval Details
Approval Id
2523a71a496105f6
Drug Approval Philippines Name
Ninlaro
Product Name
Ninlaro
Registration Number
DR-XY46357
Brand Name
Ninlaro
Generic Name
Ixazomib (As Citrate)
Dosage Form
Capsule
Dosage Strength
3 mg
Manufacturer
Haupt Pharma Amareg GmbH
Importer
Takeda Healthcare Philippines, Inc.
Distributor
Takeda Healthcare Philippines, Inc.
Company Detail Path
/organization/haupt-pharma-amareg-gmbh
Issuance Date
14 April 2023
Expiry Date
14 April 2028
Pharmacologic Category
Antineoplastic Agent (Protease Inhibitor)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
2523a71a496105f6
Type
Standard
Back to Philippines FDA Approvals